It's a gambler's game even today.
So, we had to do that gamble.
We obtained an influenza vaccine,
we applied it to our Nanopatches
and we applied the Nanopatches to the skin,
and we waited --
and this is in the live animal.
We waited a month,
and this is what we found out.
This is a data slide showing the immune responses
that we've generated with a Nanopatch
compared to the needle and syringe into muscle.
So on the horizontal axis we have
the dose shown in nanograms.
On the vertical axis we have
the immune response generated,
and that dashed line indicates
the protection threshold.
If we're above that line it's considered protective;
if we're below that line it's not.
So the red line is mostly below that curve
and indeed there's only one point that
is achieved with the needle that's protective,
and that's with a high dose of 6,000 nanograms.
But notice immediately the distinctly different curve